Skip to content

Author

Giovanni Esposito

We have 2 of 29 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Early Initiation of Sodium-Glucose Cotransporter 2 Inhibitors in Acute Decompensated Heart Failure: Efficacy, Safety, and Implementation in Stabilized Patients

Sodium-glucose cotransporter 2 (SGLT2) inhibitors have fundamentally reshaped the pharmacological management of chronic heart failure (HF). However, the role of these inhibitors during the vulnerable phase of acute decompensated heart failure (ADHF) has historically been limited by concerns regarding hemodynamic stabil...

A. Mauriello, Adriana Correra, A. Maratea et al. · 0 citations
Open access Aug 2026

LDL Cholesterol Lowering With Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction: The AMUNDSEN Randomized Clinical Trial.

In patients with acute MI undergoing PCI, first-line evolocumab combined with high-intensity lipid-lowering therapy produced rapid and sustained LDL-C reduction, with more than 80% of patients reaching the guideline-recommended target at 1 year.

G. Montalescot, E. Ferrari, G. Souteyrand et al. · 3 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.